Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ashoke Khanwalkar

Concepts (125)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Paranasal Sinuses
4
2023
77
2.260
Why?
Nasal Surgical Procedures
3
2023
6
2.100
Why?
Rhinitis
6
2025
159
1.480
Why?
Tranexamic Acid
2
2023
63
1.400
Why?
Endoscopy
6
2026
316
1.300
Why?
Sinusitis
5
2025
221
1.260
Why?
Lymphatic Abnormalities
2
2020
20
1.140
Why?
Nose Diseases
3
2025
17
1.080
Why?
Nasal Obstruction
3
2022
26
1.010
Why?
Olfaction Disorders
5
2026
74
0.840
Why?
Nasal Polyps
1
2024
59
0.800
Why?
Telangiectasia, Hereditary Hemorrhagic
1
2022
14
0.700
Why?
Antifibrinolytic Agents
1
2023
68
0.700
Why?
Smell
5
2026
129
0.670
Why?
Biological Products
1
2024
258
0.650
Why?
Cystic Fibrosis
6
2026
1164
0.620
Why?
Otorhinolaryngologic Surgical Procedures
1
2020
39
0.610
Why?
Neck
1
2020
107
0.600
Why?
Hydrocodone
1
2018
20
0.570
Why?
Dyspnea
1
2020
251
0.540
Why?
Mesothelioma
2
2015
50
0.530
Why?
Betacoronavirus
1
2020
288
0.500
Why?
Intubation, Intratracheal
1
2020
330
0.500
Why?
Postoperative Complications
2
2020
3034
0.460
Why?
Acetaminophen
1
2018
268
0.460
Why?
Inpatients
1
2020
540
0.460
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
344
0.450
Why?
Respiratory Tract Infections
1
2020
403
0.450
Why?
Pleural Neoplasms
1
2015
31
0.440
Why?
Respiration, Artificial
1
2020
711
0.430
Why?
Minimal Clinically Important Difference
2
2026
35
0.430
Why?
Pneumonia, Viral
1
2020
387
0.430
Why?
Coronavirus Infections
1
2020
379
0.430
Why?
Patient Reported Outcome Measures
1
2018
516
0.410
Why?
Epistaxis
2
2023
16
0.370
Why?
Turbinates
2
2022
14
0.340
Why?
Chronic Disease
7
2026
1827
0.340
Why?
Aminophenols
2
2024
204
0.330
Why?
Analgesics, Opioid
1
2018
1221
0.300
Why?
Quality of Life
6
2026
3200
0.300
Why?
Telemedicine
1
2018
966
0.290
Why?
Humans
25
2026
146342
0.240
Why?
Goldenhar Syndrome
1
2025
11
0.230
Why?
Cranial Fossa, Middle
1
2025
17
0.230
Why?
Hamartoma
1
2025
29
0.230
Why?
Drug Combinations
3
2024
400
0.220
Why?
Fistula
1
2025
45
0.220
Why?
Benzodioxoles
2
2024
164
0.220
Why?
Nasal Cavity
2
2025
60
0.220
Why?
Treatment Outcome
5
2024
11821
0.210
Why?
Omalizumab
1
2024
44
0.210
Why?
Prospective Studies
8
2026
8123
0.210
Why?
Intracranial Hypotension
1
2025
67
0.200
Why?
Food Preferences
1
2025
126
0.200
Why?
Indoles
2
2024
511
0.190
Why?
Platelet-Rich Plasma
1
2022
44
0.180
Why?
Cautery
1
2022
4
0.180
Why?
Blood Loss, Surgical
1
2023
117
0.180
Why?
Lung Neoplasms
1
2015
2675
0.170
Why?
Vibration
1
2021
70
0.170
Why?
Bevacizumab
1
2022
169
0.170
Why?
Rhinoplasty
1
2021
38
0.160
Why?
Seroma
1
2020
3
0.160
Why?
Vascular Endothelial Growth Factor A
1
2022
545
0.140
Why?
Hypersensitivity
1
2022
253
0.140
Why?
Return to Work
1
2018
21
0.140
Why?
Visual Analog Scale
1
2018
33
0.140
Why?
Retrospective Studies
4
2025
17438
0.140
Why?
Female
12
2026
79499
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2024
992
0.130
Why?
Double-Blind Method
1
2023
2070
0.130
Why?
Male
10
2026
73396
0.130
Why?
Tumor Burden
2
2015
326
0.130
Why?
Operative Time
1
2018
195
0.130
Why?
Middle Aged
8
2026
36619
0.120
Why?
Tertiary Care Centers
1
2018
196
0.120
Why?
Randomized Controlled Trials as Topic
1
2021
1763
0.100
Why?
Diffusion Magnetic Resonance Imaging
1
2015
158
0.100
Why?
Child, Preschool
2
2020
11913
0.100
Why?
Positron-Emission Tomography
1
2015
343
0.100
Why?
Adult
8
2026
41087
0.100
Why?
Tomography, X-Ray Computed
3
2025
2786
0.090
Why?
Surveys and Questionnaires
5
2025
6073
0.090
Why?
Mentors
1
2014
217
0.090
Why?
Length of Stay
1
2018
1358
0.090
Why?
Pandemics
1
2020
1707
0.080
Why?
Ambulatory Care Facilities
1
2014
269
0.080
Why?
Quinolones
2
2024
204
0.080
Why?
Education, Medical, Undergraduate
1
2014
208
0.080
Why?
Follow-Up Studies
1
2020
5439
0.080
Why?
Pyridines
2
2024
610
0.070
Why?
Time Factors
1
2020
7109
0.070
Why?
Students, Medical
1
2014
383
0.070
Why?
Child
2
2020
22693
0.070
Why?
Adolescent
3
2026
22557
0.070
Why?
Infant
1
2020
10114
0.060
Why?
Risk Factors
1
2020
10921
0.060
Why?
Ribonuclease III
1
2025
44
0.060
Why?
Clinical Competence
1
2014
1272
0.060
Why?
Aged
3
2021
26432
0.050
Why?
DEAD-box RNA Helicases
1
2025
90
0.050
Why?
Young Adult
3
2026
14330
0.050
Why?
Pyrrolidines
1
2023
127
0.050
Why?
Genetic Testing
1
2025
492
0.050
Why?
Social Class
1
2024
260
0.040
Why?
Nose
1
2022
67
0.040
Why?
Ribs
1
2021
35
0.040
Why?
Patient Health Questionnaire
1
2021
43
0.040
Why?
Syndrome
1
2021
380
0.040
Why?
Postoperative Period
1
2021
355
0.040
Why?
Cadaver
1
2021
304
0.040
Why?
Pyrazoles
1
2023
517
0.040
Why?
Cartilage
1
2021
198
0.040
Why?
Cost of Illness
1
2022
323
0.040
Why?
Sex Factors
1
2024
2107
0.030
Why?
Aged, 80 and over
2
2021
8391
0.030
Why?
Volunteers
1
2014
40
0.020
Why?
Lymphatic Metastasis
1
2015
335
0.020
Why?
Cross-Sectional Studies
1
2025
5899
0.020
Why?
Animals
1
2015
38107
0.020
Why?
Peer Group
1
2014
251
0.020
Why?
Interpersonal Relations
1
2014
387
0.020
Why?
Neoplasm Staging
1
2015
1488
0.020
Why?
Program Evaluation
1
2014
952
0.020
Why?
Logistic Models
1
2014
2126
0.020
Why?
Khanwalkar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)